Delisted from Euronext Amsterdam in June 2023
DSM - Koninklijke DSM N.V.
AMS
->
Basic Materials
->
Specialty Chemicals
Heerlen,
Netherlands
Type: Equity
DSM price evolution
DSM
| (in millions $) | 30 Dec 2022 | 1 Jul 2022 | 30 Mar 2022 | 30 Dec 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $5.87 | $792 | $1561 | |
| Short term investments | $838 | $838 | $489 | |
| Net receivables | $7.51 | $1774 | $1691 | |
| Inventory | $2394 | $2394 | $2297 | |
| Total current assets | $7579 | $7579 | $6129 | |
| Long term investments | $266 | $266 | $259 | |
| Property, plant & equipment | $3570 | $3570 | $3957 | |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $529.37 | $16853 | $16013 | |
| Current liabilities | ||||
| Accounts payable | $1.69 | $1541 | $1561 | |
| Deferred revenue | ||||
| Short long term debt | $98 | $98 | $13 | |
| Total current liabilities | $3020 | $3020 | $2431 | |
| Long term debt | $121.16 | $2985 | $2842 | |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $125.06 | $7030 | $6616 | |
| Shareholders' equity | ||||
| Retained earnings | -$13.42 | $8552 | $8540 | |
| Other shareholder equity | $595 | $595 | $156 | |
| Total shareholder equity | $9731 | $9731 | $9318 | |
| (in millions $) | 30 Dec 2022 | 30 Dec 2021 | 30 Dec 2020 | 30 Dec 2019 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $0.33 | $1561 | $871 | $800 |
| Short term investments | $489 | $43 | $688 | |
| Net receivables | $7.66 | $1691 | $1483 | $1696 |
| Inventory | $2297 | $1879 | $2019 | |
| Total current assets | $8.01 | $6129 | $5425 | $5224 |
| Long term investments | $259 | $321 | $312 | |
| Property, plant & equipment | $3957 | $3774 | $4040 | |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $492.71 | $16013 | $14364 | $13443 |
| Current liabilities | ||||
| Accounts payable | $0.87 | $1561 | $1207 | $1338 |
| Deferred revenue | ||||
| Short long term debt | $13 | $7 | $8 | |
| Total current liabilities | $2.14 | $2431 | $2264 | $2163 |
| Long term debt | $116.41 | $2842 | $3311 | $2277 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $118.75 | $6616 | $6877 | $5608 |
| Shareholders' equity | ||||
| Retained earnings | -$43.77 | $8540 | $7791 | $7713 |
| Other shareholder equity | $156 | -$243 | $96 | |
| Total shareholder equity | $9318 | $7399 | $7731 | |
| (in millions $) | 30 Dec 2022 | 1 Jul 2022 | 30 Mar 2022 | 30 Dec 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $10.77 | $10.81 | $2057.5 | $2358 |
| Cost of revenue | $1344.5 | $3020 | ||
| Gross Profit | $8.41 | $9.08 | $713 | -$662 |
| Operating activities | ||||
| Research & development | $161.5 | |||
| Selling, general & administrative | $890 | |||
| Total operating expenses | $0.64 | $0.74 | $1858.5 | $2149.5 |
| Operating income | $199 | $208.5 | ||
| Income from continuing operations | ||||
| EBIT | $199 | $208.5 | ||
| Income tax expense | $36 | $39 | ||
| Interest expense | -$29.1 | -$58.85 | -$19.5 | -$12 |
| Net income | ||||
| Net income | -$21.85 | -$50.3 | $225 | $334 |
| Income (for common shares) | $224.5 | $333 | ||
| (in millions $) | 30 Dec 2022 | 30 Dec 2021 | 30 Dec 2020 | 30 Dec 2019 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $21.58 | $9204 | $8106 | $7998 |
| Cost of revenue | $6040 | $5330 | $5234 | |
| Gross Profit | $17.49 | $3164 | $2776 | $2764 |
| Operating activities | ||||
| Research & development | $323 | $398 | $295 | |
| Selling, general & administrative | $1780 | $1622 | $1639 | |
| Total operating expenses | $1.39 | $8181 | $7434 | $7191 |
| Operating income | $1023 | $672 | $807 | |
| Income from continuing operations | ||||
| EBIT | $1023 | $672 | $807 | |
| Income tax expense | $168 | $106 | $145 | |
| Interest expense | -$87.95 | -$92 | -$90 | -$96 |
| Net income | ||||
| Net income | -$72.26 | $1676 | $506 | $758 |
| Income (for common shares) | $1670 | $499 | $750 | |
| (in millions $) | 30 Dec 2022 | 1 Jul 2022 | 30 Mar 2022 | 30 Dec 2021 |
|---|---|---|---|---|
| Net income | $225 | $334 | ||
| Operating activities | ||||
| Depreciation | $148 | $163.5 | ||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $149.5 | $424 | ||
| Investing activities | ||||
| Capital expenditures | -$149.5 | -$98.5 | ||
| Investments | -$174 | -$96.5 | ||
| Total cash flows from investing | -$323 | -$390.5 | ||
| Financing activities | ||||
| Dividends paid | -$16.25 | -$7.35 | -$86 | |
| Sale and purchase of stock | ||||
| Net borrowings | -$14.5 | $4.5 | ||
| Total cash flows from financing | -$38.54 | -$24.89 | -$218.5 | -$97 |
| Effect of exchange rate | $7.5 | $24 | ||
| Change in cash and equivalents | $0.29 | $5.82 | -$384.5 | -$39.5 |
| (in millions $) | 30 Dec 2022 | 30 Dec 2021 | 30 Dec 2020 | 30 Dec 2019 |
|---|---|---|---|---|
| Net income | $1676 | $506 | $758 | |
| Operating activities | ||||
| Depreciation | $646 | $587 | $526 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $1427 | $1494 | $1385 | |
| Investing activities | ||||
| Capital expenditures | -$433 | -$458 | -$520 | |
| Investments | -$365 | $673 | $536 | |
| Total cash flows from investing | $208 | -$1482 | -$525 | |
| Financing activities | ||||
| Dividends paid | -$16.25 | -$266 | -$289 | -$291 |
| Sale and purchase of stock | ||||
| Net borrowings | -$518 | $705 | -$291 | |
| Total cash flows from financing | -$38.54 | -$984 | $83 | -$1332 |
| Effect of exchange rate | $39 | -$24 | -$9 | |
| Change in cash and equivalents | $0.29 | $690 | $71 | -$481 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | $4.44B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $486.85M |
| Revenue Q/Q | -99.54% |
| Revenue Y/Y | -50.29% |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | N/A |
| Quick ratio | N/A |